[Federal Register Volume 74, Number 64 (Monday, April 6, 2009)]
[Notices]
[Pages 15500-15501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7714]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice
of Meeting
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the National
Advisory Council for Complementary and Alternative Medicine (NACCAM)
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and/or contract
proposals and the discussion could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
[[Page 15501]]
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Complementary
and Alternative Medicine.
Date: June 5, 2009.
Closed: 8:30 a.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Open: 11 a.m. to 4 p.m.
Agenda: Opening remarks by the Director of the National Center
for Complementary and Alternative Medicine, presentation of a new
research initiative, and other business of the Council.
Place: National Institutes of Health, Neuroscience Building,
6001 Executive Boulevard, Conference Rooms C & D, Bethesda, MD
20892.
Contact Person: Martin H. Goldrosen, PhD, Executive Secretary,
Director, Division of Extramural Activities, National Center for
Complementary and Alternative Medicine, National Institutes of
Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301)
594-2014.
The public comments session is scheduled from 3:30-4 p.m., but
could change depending on the actual time spent on each agenda item.
Each speaker will be permitted 5 minutes for their presentation.
Interested individuals and representatives of organizations are
requested to notify Dr. Martin H. Goldrosen, National Center for
Complementary and Alternative Medicine, NIH, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax:
301-480-9970. Letters of intent to present comments, along with a
brief description of the organization represented, should be
received no later than 5 p.m. on June 1, 2009. Only one
representative of an organization may present oral comments. Any
person attending the meeting who does not request an opportunity to
speak in advance of the meeting may be considered for oral
presentation, if time permits, and at the discretion of the
Chairperson. In addition, written comments may be submitted to Dr.
Martin H. Goldrosen at the address listed above up to ten calendar
days (June 15, 2009) following the meeting.
Copies of the meeting agenda and the roster of members will be
furnished upon request by contacting Dr. Martin H. Goldrosen,
Executive Secretary, NACCAM, National Center for Complementary and
Alternative Medicine, National Institutes of Health, 6707 Democracy
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax
301-480-9970, or via e-mail at [email protected].
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign in at the security desk upon entering the
building.
Dated: March 31, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-7714 Filed 4-3-09; 8:45 am]
BILLING CODE 4140-01-P